Log In
Print
BCIQ
Print
Print this Print this
 

VAC-3S

  Manage Alerts
Collapse Summary General Information
Company InnaVirVax S.A.
DescriptionGp41 peptide that inhibits reductions in CD4+ T cell count
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase I/II
IndicationHIV / AIDS
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today